in 74 patients with clonorchiasis , the efficacy and safety of praziquantel was evaluated in a two-phase study : a double-blind , randomized controlled trial of praziquantel versus placebo ( 42 patients ) and an open study ( 32 patients ) .
C0009021
clonorchiasis
C0032911
praziquantel